| Net loss per share |
The following table summarizes the computation of basic and diluted net loss per share of the Company (in thousands, except share and per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss, as reported |
|
$ |
(21,860 |
) |
|
$ |
(31,537 |
) |
|
$ |
(46,404 |
) |
|
$ |
(4,312 |
) |
Less: increase in available income |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Diluted net loss |
|
$ |
(21,860 |
) |
|
$ |
(31,537 |
) |
|
$ |
(46,404 |
) |
|
$ |
(4,312 |
) |
Weighted average shares outstanding, basic |
|
|
10,461,954 |
|
|
|
10,369,535 |
|
|
|
10,432,125 |
|
|
|
9,716,895 |
|
Add: Weighted average shares issuable |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
Weighted average shares outstanding, diluted |
|
|
10,461,954 |
|
|
|
10,369,535 |
|
|
|
10,432,125 |
|
|
|
9,716,895 |
|
Net loss per share - basic |
|
$ |
(2.09 |
) |
|
$ |
(3.04 |
) |
|
$ |
(4.45 |
) |
|
$ |
(0.44 |
) |
Net loss per share - diluted |
|
$ |
(2.09 |
) |
|
$ |
(3.04 |
) |
|
$ |
(4.45 |
) |
|
$ |
(0.44 |
) |
The Company excluded the following potential shares of Common Stock, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Options to purchase common stock |
|
|
2,154,864 |
|
|
|
1,678,221 |
|
|
|
2,154,864 |
|
|
|
1,678,221 |
|
Unvested restricted stock |
|
|
68,776 |
|
|
|
76,861 |
|
|
|
68,776 |
|
|
|
76,861 |
|
Common warrants to purchase common stock |
|
|
4,213,767 |
|
|
|
4,213,767 |
|
|
|
4,213,767 |
|
|
|
4,213,767 |
|
|
|
|
6,437,407 |
|
|
|
5,968,849 |
|
|
|
6,437,407 |
|
|
|
5,968,849 |
|
|